sertraline
Boxed Warning
Suicidality risk in children, adolescents, and young adults under 25 during initial treatment.
Sertraline is an SSRI antidepressant approved for major depressive disorder, OCD, panic disorder, PTSD, social anxiety disorder, and premenstrual dysphoric disorder. It is one of the most widely prescribed antidepressants worldwide.
25mg, 50mg, 100mg, 200mg
Tablets: 25mg, 50mg, 100mg; Oral concentrate: 20mg/mL
Category C (risk cannot be ruled out)
Potent and selective inhibitor of serotonin reuptake at the presynaptic membrane (SERT), with minimal effects on norepinephrine and dopamine reuptake. Also has mild affinity for the dopamine transporter.
Liquid formulation available for precise dosing. Hyperbolic taper recommended.
Follow hyperbolic reduction schedule. Liquid concentrate (20mg/mL) useful for fine adjustments.
Evidence-based phased reduction schedule. Always taper under medical supervision.
| Phase | Duration | Notes |
|---|---|---|
| Initial reductions | ~4 weeks | Larger steps using available tablet strengths. Generally well tolerated at higher doses. |
| Middle reductions | 4-6 weeks | Smaller tablet strengths for more gradual changes. Monitor for GI disturbance. |
| Lower dose reductions | 6-8 weeks | Ask your prescriber about oral concentrate for more precise adjustments at lower doses. |
| Final reductions | 6-10 weeks | The lowest doses often require the slowest approach. Work with your prescriber on liquid dosing. |
1-2 days after dose reduction
3-7 days
2-3 weeks for acute symptoms
GI symptoms and irritability may linger 4-8 weeks. Brain zaps typically resolve within 1 month.
Practical insights shared by members tapering Zoloft. Not medical advice — always consult your prescriber.
Toxicity
Serotonin syndrome in overdose or with serotonergic combinations. QT prolongation reported rarely. GI bleeding risk increased with NSAIDs.
Pharmacokinetics
Slowly absorbed after oral administration, Tmax 4.5–8.4 hours. Bioavailability subject to extensive first-pass metabolism. Food increases Tmax slightly.
~20 L/kg
Extensive hepatic metabolism primarily via CYP2B6, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 to N-desmethylsertraline (substantially less active).
Renal (~40–45% as metabolites) and fecal (~40–45%). Less than 0.2% excreted unchanged in urine.
~98%
~1.5 L/min (oral clearance)
Browse our map of deprescribing-informed providers worldwide.